The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease and heart failure

Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up

EuroIntervention 2016;11:1126-1131 published online ahead of print September 2015. DOI: 10.4244/EIJY15M09_01

1. Cardiology Unit, University of Rome “Tor Vergata”, Rome, Italy; 2. Cardiac Surgery, St. Francis Hospital, Hartford, CT, USA; 3. Anesthesiology Unit, University of Rome “Tor Vergata”, Rome, Italy; 4. Cardiac Surgery Unit, University of Rome “Tor Vergata

Aims: Transcatheter mitral valve implantation for mitral valve regurgitation is in the very early phase of development because of challenging anatomy and device dimensions. We describe th

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Feasibility and safety of balloon-expandable transcatheter aortic valve implantation with moderate or without predilatation